prikaz prve stranice dokumenta Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma
  Download
PDF 118.87 KB
Scientific paper - Original scientific paper
Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma
Collegium Antropologicum, 30 (2006), 4; 743-748. urn:nbn:hr:105:642920
Balenović, Antonija; Vlašić, Marko; Sonicki, Zdenko; Bodor, Davor; Kusić, Zvonko

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Balenović, A., Vlašić, M., Sonicki, Z., Bodor, D. & Kusić, Z. (2006). Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Collegium Antropologicum, 30. (4), 743-748. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:642920

Balenović, Antonija, et al. "Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma." Collegium Antropologicum, vol. 30, no. 4, 2006, pp. 743-748. https://urn.nsk.hr/urn:nbn:hr:105:642920

Balenović, Antonija, Marko Vlašić, Zdenko Sonicki, Davor Bodor and Zvonko Kusić. "Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma." Collegium Antropologicum 30, no. 4 (2006): 743-748. https://urn.nsk.hr/urn:nbn:hr:105:642920

Balenović, A., et al. (2006) 'Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma', Collegium Antropologicum, 30(4), pp. 743-748. Available at: https://urn.nsk.hr/urn:nbn:hr:105:642920 (Accessed 27 April 2024)

Balenović A, Vlašić M, Sonicki Z, Bodor D, Kusić Z. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Collegium Antropologicum [Internet]. 2006 December [cited 2024 April 27];30(4):743-748. Available at: https://urn.nsk.hr/urn:nbn:hr:105:642920

A. Balenović, M. Vlašić, Z. Sonicki, D. Bodor and Z. Kusić, "Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma", Collegium Antropologicum, vol. 30, no. 4, pp. 743-748, December 2006. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:642920. [Accessed: 27 April 2024]

Metadata
Title (english)Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma
AuthorAntonija Balenović
AuthorMarko Vlašić
AuthorZdenko Sonicki
AuthorDavor Bodor
AuthorZvonko Kusić
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
The aim of the study was to investigate the influence of radioiodine (RAI) therapy on pregnancies and the health status of children born to mothers who had received therapeutic doses of I-131 for differentiated thyroid carcinoma (DTC). Gestational histories of 76 women treated for DTC from 1971-2005 were retrospectively analyzed. The outcome of 49 pregnancies after RAI was: 35 children (72%), 5 (10%) miscarriages and 9 (18%) induced abortions. RAI did not adversely affect the rate of successful delivery and live birth demographics. Congenital malformation and first year mortality were not observed. The children's ages range from 1 month to 29 years (chi+/-SD=8.0+/-8.4). A higher therapeutic dose (>100 mCi) did not significantly alter the pregnancy outcome. There is no reason to discourage females treated with 1-131 from becoming pregnant. Patients should avoid pregnancy after RAI administration for 1 year.
Abstract (croatian)
Cilj studije bio je utvrditi utjecaj radioaktivnog joda (RAI) na trudnoće, kao i na zdravlje djece bolesnica koje su primale terapijske doze I-131 radi diferenciranog karcinoma štitnjače (DTC). Trudnoće u 76 bolesnica liječenih radi DTC-a u periodu od 1971.–2005. g. su retrospektivno analizirane. Ishod 49 trudnoća koje su uslijedile nakon terapije RAI bio je: 35 djece (72%), 5 spontanih pobačaja (10%) i 9 arteficijalnih pobačaja (18%). Terapija radioaktivnim jodom nije negativno utjecala na stopu uspješnih poroda, niti na demografske osobine novorođenčadi. Kongenitalne malformacije i mortalitet u prvoj godini života nisu registrirani. Srednja dob djece bila je 8 godina (raspon 1 mjesec do 29 godina, SD=8.4). U bolesnica koje su primile veće terapijske doze radioaktivnog joda (>100 mCi) nije registriran lošiji ishod. Bolesnicama liječenim radioaktivnim jodom radi diferenciranog karcinoma štitnjače nije potrebno preporučivati izbjegavanje trudnoće. Preporuča se izbjegavati trudnoću u godini neposredno nakon primanja terapije I-131.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleCollegium Antropologicum
Numberingvol. 30, no. 4, pp. 743-748
p-ISSN0350-6134
URN:NBNurn:nbn:hr:105:642920
Publication2006-12
Document URLhttps://hrcak.srce.hr/27632
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 11:03:20